The DOI matches its Crossref record.
Prevention of Dopamine-Induced Cell Death by Thiol Antioxidants: Possible Implications for Treatment of Parkinson's Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Reactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,927
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072
“Since increases in tyrosine hydroxylaseregulated catecholamine synthesis are limited, this mechanism provides sympathetic nerves with a capacity for a more extended range of sustainable release rates than would otherwise be possible.”
BackgroundApoptosis and glutathione: beyond an antioxidant
Franco, R., & Cidlowski, J. A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.107 · Cited by 744
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540
Asanuma, M., Miyazaki, I., & Ogawa, N. (2003) · Neurotoxicity Research · doi:10.1007/bf03033137 · Cited by 516
Tanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497
Cytotoxic and genotoxic potential of dopamine
Stokes, A. H., Hastings, T. G., & Vrana, K. E. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6<659::aid-jnr1>3.0.co;2-c · Cited by 469
Cardiac Sympathetic Denervation in Parkinson Disease
Goldstein, D. S., Holmes, C., Li, S.-T., Bruce, S., Metman, L. V., & Cannon, R. O. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-5-200009050-00009 · Cited by 371
BAEZ, S., SEGURA-AGUILAR, J., WIDERSTEN, M., JOHANSSON, A.-S., & MANNERVIK, B. (1997) · Biochemical Journal · doi:10.1042/bj3240025 · Cited by 340
Melatonin and cell death: differential actions on apoptosis in normal and cancer cells
Sainz, R. M., Mayo, J. C., Rodriguez, C., Tan, D. X., Lopez-Burillo, S., & Reiter, R. J. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2319-1 · Cited by 305
Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
Tardiolo, G., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23123305 · Cited by 285
SCHORE, A. N. (1997) · Development and Psychopathology · doi:10.1017/s0954579497001363 · Cited by 283
Oxidative Stress in Pulmonary Fibrosis
Otoupalova, E., Smith, S., Cheng, G., & Thannickal, V. J. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190017 · Cited by 262
N‐Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
Monti, D. A., Zabrecky, G., Kremens, D., Liang, T., Wintering, N. A., Bazzan, A. J., Zhong, L., Bowens, B. K., Chervoneva, I., Intenzo, C., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1548 · Cited by 121
Zheng, H., Youdim, M. B. H., Weiner, L. M., & Fridkin, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.003 · Cited by 53
Metadata
- Authors
- Offen, D., Ziv, I., Sternin, H., Melamed, E., & Hochman, A.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 1996-09
- Volume
- 141
- Issue
- 1
- Pages
- 32-39
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1969291345
- Cited by
- 250
- References
- 0
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.